KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Change in Account Payables (2020 - 2024)

AbCellera Biologics filings provide 5 years of Change in Account Payables readings, the most recent being $130000.0 for Q3 2024.

  • Quarterly Change in Account Payables fell 99.1% to $130000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $14.4 million through Sep 2024, up 3845.48% year-over-year, with the annual reading at $1.1 million for FY2022, 122.99% up from the prior year.
  • Change in Account Payables hit $130000.0 in Q3 2024 for AbCellera Biologics, down from $4.7 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $27.3 million in Q2 2022 and bottomed at -$29.2 million in Q3 2022.
  • Average Change in Account Payables over 5 years is $1.2 million, with a median of $1.1 million recorded in 2020.
  • The largest annual shift saw Change in Account Payables tumbled 4473.08% in 2021 before it skyrocketed 681.28% in 2022.
  • AbCellera Biologics' Change in Account Payables stood at $24.3 million in 2020, then plummeted by 117.83% to -$4.3 million in 2021, then skyrocketed by 151.27% to $2.2 million in 2022, then soared by 549.57% to $14.4 million in 2023, then tumbled by 99.1% to $130000.0 in 2024.
  • Per Business Quant, the three most recent readings for ABCL's Change in Account Payables are $130000.0 (Q3 2024), $4.7 million (Q2 2024), and -$4.9 million (Q1 2024).